Clinical Trial Update: Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating hepatic arterial infusion of gemcitabine and oxaliplatin as second-line therapy for non-resectable, non-metastatic intrahepatic cholang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Cholangiocarcinoma Non-resectable, Non-metastatic | Phase 2 | Status: RECRUITING